Sinlita Omesatan tablets (Sinda Yue ®) approved by the State Drug Administration
-
Last Update: 2020-06-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Recently, Xinlitai issued a notice that theCompany(http://received the NationalDrug(http://Supervision Authority approved the issuance of the Omesatan tablets (Sinda Yue ®) "Drug Registration Approval."It is understood that omesataneste for the angiotensin II receptor antagonists antihypertensivedrug(http://, its half-life is longer, with convenient to take, take a small dose, fast effect and so onOmesataneste is the National BasicMedical(http://Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition) Medical Insurance Class BProduct seine (http:// , by the "China Hypertension Prevention and Control Guide" (2018 revision), "Good Medication For Hypertension Guide" as a commonly used antihypertensive drugs Omesatan tablets original research manufacturers (http:// for Japan's first three co-companies, in 2006, the first three Pharmaceutical (http:// (Shanghai) Co., Ltd production of Omesatan ester tablets in China The announcement shows that Cinda Yue ® (Omesatan ester tablets) will be listed, will be litay (Alysatan ester tablets), Cinda Yi ® (benapurtablets) and other products to form complementary advantages, further improve the company's blood pressure reduction product chain, strengthen the company's dominant position in the field of cardiovascular vessels
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
